Pacira BioSciences, Inc. (PCRX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$25.39
-0.63%
Mkt Cap $1.09B
Next Earnings
In 2 daysThu, Apr 30, 2026
EPS Estimate
$0.55
4 analysts
Revenue Estimate
$171.80M
Last quarter: missed by -32.94% on EPS, -1.73% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.09B
P/E
172.99
Fwd P/E
8.88
P/S
1.50
Rev TTM
—
EPS TTM
$0.15